Salix Pharmaceuticals (SLXP): Q4 EPS of $1.18 beats by $0.24. Revenue of $155.1M (+31% Y/Y)...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor
Salix Pharmaceuticals (SLXP): Q4 EPS of $1.18 beats by $0.24. Revenue of $155.1M (+31% Y/Y) beats by $3M. (PR)